Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE
04:01pm, Friday, 29'th Aug 2025
THOUSAND OAKS, Calif. , Aug. 29, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 Wells Fargo Healthcare Conference at 10:15 a.m.
2 Dividend Stocks to Hold for the Next 10 Years
04:29am, Thursday, 28'th Aug 2025
The healthcare industry is a good place to look for strong dividend-paying stocks. Many companies in the sector offer products that are consistently in demand, regardless of the state of the economy.
Calls of the Day: Micron, DoorDash, Amer Sports, Amgen, Merck and Costco
01:23pm, Wednesday, 27'th Aug 2025
The Investment Committee debate the latest Calls of the Day.
AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?
09:10am, Tuesday, 26'th Aug 2025
Amgen's stock is up 13.5% in 2025, fueled by strong drug sales and new biosimilars, but looming competition and pricing headwinds pose challenges.
REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
09:00am, Monday, 25'th Aug 2025
THOUSAND OAKS, Calif. , Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha® (evolocumab) to i
Royalty Pharma to buy royalty interest in Amgen's lung cancer drug for up to $950 million
06:33am, Monday, 25'th Aug 2025
Royalty Pharma said on Monday it has signed a deal with BeOne Medicines to acquire a royalty interest in Amgen's drug for small cell lung cancer for up to $950 million.
Royalty Pharma to Acquire Royalty Interest in Amgen's Imdelltra for up to $950 Million
06:10am, Monday, 25'th Aug 2025
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a royalty interest in Amgen's Imdelltra, a first-in-class DLL3 targeting bispecific T
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:01am, Friday, 22'nd Aug 2025
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade
05:21am, Wednesday, 20'th Aug 2025
Income-seeking investors who value their time know the best dividend stocks don't need a lot of babysitting. Some go on decades-long payout-raising streaks.
Back To Basics: Why I Favor Amgen Over Johnson & Johnson
03:06pm, Thursday, 14'th Aug 2025
Both Amgen (AMGN) and Johnson & Johnson (JNJ) recently received a 60-day ultimatum to lower their prices in the U.S. market. A fundamental analysis shows AMGN to be better positioned than JNJ to absor
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
10:41am, Thursday, 14'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
10:01am, Monday, 11'th Aug 2025
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season
11:51am, Friday, 08'th Aug 2025
AMGN posts strong Q2 results as Repatha, Evenity, Blincyto and rare disease drugs power broad-based volume gains.
August Dogs Of The Dow Unleashed 19 'Safer' Dividend Buys
12:23pm, Thursday, 07'th Aug 2025
Verizon is the only Dow stock currently meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price and are supported by free cash flow. Analyst forecasts suggest top Dow
Amgen Stock Sinks As Market Eyes MariTide's Next Move
02:19pm, Wednesday, 06'th Aug 2025
Amgen Inc. AMGN shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after markets closed on Tuesday.
